Progress and Hope in the Fight Against Alzheimer's Disease
Recent advances in Alzheimer's research include the approval of two drugs, donanemab and lecanemab, which can slow disease progression but have limited effectiveness and potential side effects. A new blood test for early diagnosis has been developed, though its widespread use remains debated. Prevention efforts focus on lifestyle factors like exercise and healthy eating, but evidence of their impact on cognitive decline is limited. Progress is promising but challenges remain in treatment efficacy, diagnosis, and prevention.